Recombinant IL17A (Netakimab Biosimilar) antibody
The Mammalian Cells Monoclonal anti-IL17A (Netakimab Biosimilar) antibody has been validated for ELISA. It is suitable to detect IL17A (Netakimab Biosimilar) in samples from Human.
Catalog No. ABIN7488161
$336.06
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 7 to 8 Business Days
Quick Overview for Recombinant IL17A (Netakimab Biosimilar) antibody (ABIN7488161)
Target
IL17A (Netakimab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Mammalian Cells
Clonality
Monoclonal
Conjugate
This IL17A (Netakimab Biosimilar) antibody is un-conjugated
Application
ELISA
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Netakimab Biosimilar - Anti-IL17A mAb
-
Characteristics
- Antibody Type: IgG1-kappa
-
Purification
- Recombinant antibody expressed in mammalien cells and purified.
-
Isotype
- IgG1 kappa
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS pH 7.5
-
Storage
- -80 °C
-
Storage Comment
- store at -80°C
-
-
- IL17A (Netakimab Biosimilar)
-
Target Type
- Biosimilar
-
Background
-
AG1-25
Netakimab, the original monoclonal antibody against IL-17A, is an innovative drug for the treatment of moderate-to-severe plaque psoriasis in patients who have indications for systemic therapy or phototherapy. -
CAS-No
- 1796570-08-5
Target
-
You are here:
